CLINICAL PROFILING OF POLYCYSTIC OVARY SYNDROME PATIENTS IN KASHMIR POPULATION
Journal: Matrix Science Pharma (MSP)
Ahila Ashraf, Rajesh Singh, Shahnawaz Mir
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
ABSTRACT
Polycystic ovary syndrome (PCOS) is a widespread premenopausal hereditary disease of reproductive women with endocrinopathy and metabolic disorders. The characteristic features of PCOS include excess androgens, hirsutism, irregular menses, polycystic ovaries, and follicular failure making the women unproductive. PCOS is heterogeneous disorder, lacking the knowledge of definite mechanism of pathogenesis. The Rotterdam diagnostic criteria for defining PCOS include excess androgens, irregular or no ovulation, and polycystic ovaries. However, in the absence of auxiliary specific diagnostic criteria, PCOS is determined by hyperandrogenism and follicular failure.[8] In spite of contentious viewpoints on current criteria for PCOS diagnosis, a professional opinion based on blood testing, an ultrasound, and pelvic examination can corroborate the diagnosis.[
| Pages | 23-34 |
| Year | 2022 |
| Issue | 1 |
| Volume | 6 |
